or Try an Advanced Search...

    Technical Analysis for NTRB - Nutriband Inc.

    Grade Last Price % Change Price Change
    D 3.36 -0.30% -0.01
    NTRB closed up 0.6 percent on Wednesday, May 8, 2024, on 8 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical NTRB trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish -0.30%
    NR7 Range Contraction -0.30%
    Narrow Range Bar Range Contraction -0.30%
    Wide Bands Range Expansion -0.30%
    Oversold Stochastic Weakness -0.30%
    Fell Below 50 DMA Bearish 0.30%
    Stochastic Reached Oversold Weakness 0.30%
    Wide Bands Range Expansion 0.30%
    Down 3 Days in a Row Weakness 0.30%
    Oversold Stochastic Weakness 0.30%
    Older End-of-Day Signals for NTRB ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 15 minutes ago
    60 Minute Opening Range Breakout about 3 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Rose Above 50 DMA about 3 hours ago
    10 DMA Resistance about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NTRB Chart by TradingView
    Basic chart:

    Profile

    The Company is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Its lead product under development is its abuse deterrent fentanyl transdermal system which the Company is developing to provide clinicians and patients with an abuse deterrent transdermal fentanyl product for use in managing chronic pain requiring opioid therapy. The product is combined with properties designed to help combat the opioid crisis by deterring the abuse and misuse of fentanyl patches
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Euphoriants Opioids Chronic Pain Analgesics Heroin Morphine Fentanyl Anilides

    Is NTRB a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 IBN Coverage Initiated for Nutriband Inc.
    Apr 24 Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission
    Apr 23 Nutriband signs exclusive supplier agreement with Fit for Life
    Apr 23 Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group
    Mar 27 Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
    Mar 25 Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting
    Mar 4 Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting
    Jan 26 Nutriband CEO Publishes Letter to Shareholders
    Jan 5 Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch
    Nov 8 Nutriband Inc. Signs Supplier Agreement With KT Tape, the World Leader in Kinesiology Tape
    See more NTRB news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.9274
    52 Week Low 1.53
    Average Volume 54,671
    200-Day Moving Average 2.89
    50-Day Moving Average 3.39
    20-Day Moving Average 3.73
    10-Day Moving Average 3.48
    Average True Range 0.33
    RSI (14) 43.82
    ADX 21.56
    +DI 18.84
    -DI 16.14
    Chandelier Exit (Long, 3 ATRs) 3.59
    Chandelier Exit (Short, 3 ATRs) 4.18
    Upper Bollinger Bands 4.39
    Lower Bollinger Band 3.08
    Percent B (%b) 0.22
    BandWidth 35.09
    MACD Line -0.07
    MACD Signal Line 0.01
    MACD Histogram -0.0786
    Fundamentals Value
    Market Cap 28.51 Million
    Num Shares 8.46 Million
    EPS -0.67
    Price-to-Earnings (P/E) Ratio -5.03
    Price-to-Sales 10.45
    Price-to-Book 3.72
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.45
    Resistance 3 (R3) 3.45 3.42 3.43
    Resistance 2 (R2) 3.42 3.40 3.42 3.43
    Resistance 1 (R1) 3.40 3.39 3.41 3.40 3.42
    Pivot Point 3.37 3.37 3.38 3.37 3.37
    Support 1 (S1) 3.35 3.35 3.36 3.35 3.32
    Support 2 (S2) 3.32 3.34 3.32 3.31
    Support 3 (S3) 3.30 3.32 3.31
    Support 4 (S4) 3.30